Cephalon cephalon.com


Public list: Pharma Startups (4734) Cancer Therapeutics (1145)

Salmedix develops oncology drugs with an initial emphasis on hematologic cancers.

Salmedix develops oncology drugs with an initial emphasis on hematologic cancers.

Company (IPO / Went public)

Phone: 610-344-0200

Fax:

41 Moores Road

Frazer, 19355
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cephalon $84.5M Feb 18, 1999
Callisto Pharmaceuticals $27.2M Jan 18, 2013
Neuromed Pharmaceuticals $16.4M Jul 2, 2009
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cephalon Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pyrazolo[1,5-a]pyridine derivatives and methods of their use Dec 18, 2014 Mar 13, 2018 Patent
1,4-substituted piperidine derivatives Jun 17, 2016 Feb 27, 2018 Patent
Use of reslizumab to treat moderate to severe eosinophilic asthma Aug 28, 2015 Nov 14, 2017 Patent
Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor May 04, 2016 Apr 18, 2017 Patent
Nanoparticulate and macroparticulate formulations Mar 12, 2014 Mar 21, 2017 Patent
See all 101 patents